High dose ipilimumab (Ipi) plus temozolomide (TMZ) after progression on standard or low dose Ipi in advanced melanoma

Williamson, J; Fadlullah, MZH; Kovacsovics, M; Gibson, B; Erickson-Wayman, A; Jamison, D; Sageser, DS; Swami, U; Jeter, JM; Bowles, TL; Cannon, DM; Ben Haaland; Schroeder, J; McPherson, JP; Hyngstrom, JR; Tan, AC; Hu-Lieskovan, S

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):